HOME >> MEDICINE >> NEWS
Brain activity reflects differences in types of anxiety

All anxiety is not created equal, and a research team at the University of Illinois now has the data to prove it. The team has found compelling evidence that differing patterns of brain activity are associated with each of two types of anxiety: anxious apprehension (verbal rumination, worry) and anxious arousal (intense fear, panic, or both).

Their work appears this month online in Psychophysiology.

"This study looks at two facets of anxiety that often are not distinguished," said U. of I. psychology professor Gregory A. Miller, co-principal investigator on the study with psychology professor Wendy Heller. "We had reason to think there were different brain mechanisms, different parts of the brain active at different times, depending on what type of anxiety one is facing."

According to a recent national survey, anxiety disorders are the most commonly reported psychiatric disorders in the U.S. The Diagnostic and Statistical Manual of Mental Disorders classifies nearly a dozen different anxiety disorders, from acute stress disorder to obsessive-compulsive disorder to panic attack and PTSD. But those who study and treat patients with anxiety disorders do not always differentiate the patients who worry, fret and ruminate from those who experience the panic, rapid heartbeat or bouts of sweating that characterize anxious arousal. These two kinds of anxiety may occur alone or in combination, with potentially important implications for treatment.

To test whether neural activation patterns supported the hypothesis that these two categories of anxiety are distinct, the researchers selected 42 subjects from a pool of 1,099 undergraduate college students, using psychological tests to categorize them as "high anxious apprehension," "high anxious arousal," or neither.

Other psychological assessments standardized the pool of participants by removing those with mood disorders or other complicating factors.

The researcher
'"/>

Contact: Diana Yates
diya@uiuc.edu
217-333-5802
University of Illinois at Urbana-Champaign
29-May-2007


Page: 1 2 3

Related medicine news :

1. Brain-boosting pill alleviates post-chemotherapy fogginess
2. Brain inflammation may be friend, not foe, for Alzheimers patients
3. Brain research poised to dramatically advance global society
4. Elsevier announces launch of Brain Stimulation
5. Brains scans of symptomatic Gulf War veterans show differences
6. Brain structure changes years before memory loss begins
7. Brain studies reveal the mechanisms of the voluntary control of visual attention
8. Brains can recover from alcoholic damage but patients should stop drinking as soon as possible
9. Brain images show hysteria not an imaginary disorder
10. Brain changes in patients with migraine
11. Brain cell and face perception research wins Eppendorf/Science Prize

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... Coalition ... for Duchenne muscular dystrophy, and funding for Duchenne research, congratulates Capricor Therapeutics ... HOPE clinical trial in Duchenne announced today. , Coalition Duchenne funded studies ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... Liberty attempts to compare student test score performance for the 2015-16 school year ... the state’s voucher programs. Though it highlights important patterns in student test score ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who ... achieves results in a fraction of the time as traditional braces – Wilckodontics®. ... Dental Specialists, now offers this revolutionary treatment with or without a referral. ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Back ... neck and back pain with a reputable physician in their area, announces the launch ... protects patient information for patients who are looking for reputable physicians to help them ...
(Date:4/25/2017)... ... 25, 2017 , ... Somnoware, a leading provider of digital ... module. Using this new feature, sleep physicians can now predict the likelihood of ... airway pressure (CPAP), oral, or other forms of sleep apnea therapy. The Somnoware ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
(Date:4/18/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 6.35% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
Breaking Medicine Technology:
Cached News: